Filtern
Erscheinungsjahr
- 2021 (8) (entfernen)
Dokumenttyp
- Wissenschaftlicher Artikel (8) (entfernen)
Volltext vorhanden
- ja (8) (entfernen)
Schlagworte
- Aggregation-prone (1)
- Bewertung (1)
- Bone morphogenetic protein 2 (1)
- Deutschland. Bundeskartellamt (1)
- Due Diligence (1)
- E. coli SHuffle® T7 (1)
- Erlass (1)
- Europäische Union (1)
- Genossenschaft (1)
- Grundfreiheiten (1)
Institut
Die wechselseitigen Beeinflussungen zwischen Werbungtreibenden und Journalist*innen werden auf Basis der empirischen Synchronisationsforschung dargestellt – mit Schwerpunkt auf Einflüsse durch Sonderwerbeformen der Online-Kommunikation. Die Argumentation richtet sich gegen eine Intensivierung der Beeinflussungsversuche. Sie spricht sich für kooperative und gekennzeichnete Produktentwicklungen aus, die zentrale Determinanten wie Personae oder Markenimages des beworbenen Produkts und des Mediums berücksichtigen. So wird der Trennungsgrundsatz eingehalten und der Charakter publizistischer Massenmedien respektiert.
Biomimetics is the interdisciplinary co-operation of various scientific disciplines and fields of innovation, and it aims to solve practical problems using biological models. Biomimetic research and its fields of application are manifold, and the community is made up of a wide range of disciplines, from biologists and engineers to designers. Guidelines and standards can build a common ground for understanding of the field, communication across disciplines, present and future projects and implementation of biomimetic knowledge. Since 2015, three international standards have been published and defined terms and definitions, as well as specific applications. The scientific literature and patents in several databases were searched for citations of the published standards. Standards or technical guidelines on biomimetics are represented both in the scientific literature and in patents. However, taking into account the increasing number of publications in biomimetics, the number of publications (52) citing the international standards is low. This shows that the perception of technical rules is still underrepresented in the academic field. Greater awareness and acceptance of the importance of standards for quality assurance even in the academic environment is discussed, and active participation in the corresponding International Organization for Standardization committee on biomimetics is asked for.
Bone morphogenetic protein 2 (BMP21) is a highly interesting therapeutic growth factor due to its strong osteogenic/osteoinductive potential. However, its pronounced aggregation tendency renders recombinant and soluble production troublesome and complex. While prokaryotic expression systems can provide BMP2 in large amounts, the typically insoluble protein requires complex denaturation-renaturation procedures with medically hazardous reagents to obtain natively folded homodimeric BMP2. Based on a detailed aggregation analysis of wildtype BMP2, we designed a hydrophilic variant of BMP2 additionally containing an improved heparin binding site (BMP2-2Hep-7M). Consecutive optimization of BMP2-2Hep-7M expression and purification enabled production of soluble dimeric BMP2-2Hep-7M in high yield in E. coli. This was achieved by a) increasing protein hydrophilicity via introducing seven point mutations within aggregation hot spots of wildtype BMP2 and a longer N-terminus resulting in higher affinity for heparin, b) by employing E. coli strain SHuffle® T7, which enables the structurally essential disulfide-bond formation in BMP2 in the cytoplasm, c) by using BMP2 variant characteristic soluble expression conditions and application of L-arginine as solubility enhancer. The BMP2 variant BMP2-2Hep-7M shows strongly attenuated although not completely eliminated aggregation tendency.